看点view本周,新版《中国药典》发布,集采有新动向,“岐黄学者”被查;药品市场迎变局,新一批重点监控药品名单出炉,48个品种集采来袭,大批常用药遭处理;研发新进展,东阳光药、青峰医药1类新药获批,恒瑞、联邦制药掀出海热潮;企业大新闻,知名中药企业“爆雷”,方盛制药加码中药矩阵……医药行业一周大事件,精彩不容错过!米内一周TOP榜米内数据第11批国采54个超“卷”品种备战!倍特、齐鲁蓄力12个独家...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.